Milestone Pharmaceuticals Inc. - Common Shares (MIST)
CUSIP: 59935V107
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 124,031,000
- Total 13F shares
- 9,242,998
- Share change
- -2,941,889
- Total reported value
- $17,005,883
- Price per share
- $1.84
- Number of holders
- 16
- Value change
- -$32,694,365
- Number of buys
- 7
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 59935V107?
CUSIP 59935V107 identifies MIST - Milestone Pharmaceuticals Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 59935V107:
Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3.2%
|
3,958,264
|
$63,372,000 | — | 31 Dec 2019 | |
| Novo Holdings A/S |
13F
|
Company |
2%
|
2,434,470
|
$38,976,000 | — | 31 Dec 2019 | |
| VHCP Management III, LLC |
13F
|
Company |
1.7%
|
2,066,529
|
$33,085,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
1,286,507
|
$20,597,000 | — | 31 Dec 2019 | |
| Boxer Capital, LLC |
13F
|
Company |
0.89%
|
1,102,194
|
$17,646,000 | — | 31 Dec 2019 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.6%
|
746,653
|
$11,954,000 | — | 31 Dec 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.48%
|
600,000
|
$9,606,000 | — | 31 Dec 2019 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.41%
|
508,500
|
$8,141,000 | — | 31 Dec 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.29%
|
364,206
|
$5,831,000 | — | 31 Dec 2019 | |
| Invesco Ltd. |
13F
|
Company |
0.26%
|
322,433
|
$5,162,000 | — | 31 Dec 2019 | |
| FMR LLC |
13F
|
Company |
0.19%
|
239,600
|
$3,836,000 | — | 31 Dec 2019 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.19%
|
235,000
|
$3,762,000 | — | 31 Dec 2019 | |
| Zimmer Partners, LP |
13F
|
Company |
0.13%
|
160,000
|
$2,562,000 | — | 31 Dec 2019 | |
| VHCP Management II, LLC |
13F
|
Company |
0.12%
|
148,560
|
$2,378,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
46,771
|
$749,000 | — | 31 Dec 2019 | |
| Prosight Management, LP |
13F
|
Company |
0.03%
|
38,481
|
$616,000 | — | 31 Dec 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
36,265
|
$581,000 | — | 31 Dec 2019 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.03%
|
32,000
|
$512,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
29,494
|
$472,000 | — | 31 Dec 2019 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.02%
|
22,995
|
$368,150 | — | 31 Dec 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.02%
|
19,715
|
$316,000 | — | 31 Dec 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
900
|
$14,000 | — | 31 Dec 2019 | |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. |
13F
|
Company |
0%
|
245
|
$4,000 | — | 31 Dec 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
142
|
$2,000 | — | 31 Dec 2019 | |
| Wealthcare Advisory Partners LLC |
13F
|
Company |
0%
|
52
|
$1,000 | — | 31 Dec 2019 |
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q1 2020
As of 31 Mar 2020,
Milestone Pharmaceuticals Inc. - Common Shares (MIST) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,242,998 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Novo Holdings A/S, BOXER CAPITAL, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., Tekla Capital Management LLC, Ghost Tree Capital, LLC, MILLENNIUM MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., and MORGAN STANLEY.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
25
Q1 2020 holders
16
Holder diff
-9
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.